nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.305	0.72	CbGbCtD
Vardenafil—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.119	0.281	CbGbCtD
Vardenafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.0127	0.0547	CbGpPWpGaD
Vardenafil—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.035	CcSEcCtD
Vardenafil—PDE10A—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.0114	0.0487	CbGpPWpGaD
Vardenafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.0114	0.0487	CbGpPWpGaD
Vardenafil—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.031	CcSEcCtD
Vardenafil—PDE11A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.0101	0.0433	CbGpPWpGaD
Vardenafil—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00949	0.0277	CcSEcCtD
Vardenafil—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00905	0.0264	CcSEcCtD
Vardenafil—PDE5A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.009	0.0386	CbGpPWpGaD
Vardenafil—PDE10A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.009	0.0386	CbGpPWpGaD
Vardenafil—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00876	0.0256	CcSEcCtD
Vardenafil—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.0081	0.0236	CcSEcCtD
Vardenafil—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00762	0.0222	CcSEcCtD
Vardenafil—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00727	0.0212	CcSEcCtD
Vardenafil—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00671	0.0196	CcSEcCtD
Vardenafil—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00659	0.0192	CcSEcCtD
Vardenafil—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.0189	CcSEcCtD
Vardenafil—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00642	0.0187	CcSEcCtD
Vardenafil—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00639	0.0186	CcSEcCtD
Vardenafil—PDE1B—Nitric oxide stimulates guanylate cyclase—NOS2—focal segmental glomerulosclerosis	0.00575	0.0247	CbGpPWpGaD
Vardenafil—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00567	0.0165	CcSEcCtD
Vardenafil—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.0161	CcSEcCtD
Vardenafil—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00547	0.016	CcSEcCtD
Vardenafil—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00545	0.0159	CcSEcCtD
Vardenafil—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00536	0.0156	CcSEcCtD
Vardenafil—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.0153	CcSEcCtD
Vardenafil—PDE6G—Diseases associated with visual transduction—LPL—focal segmental glomerulosclerosis	0.00496	0.0213	CbGpPWpGaD
Vardenafil—PDE11A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.00496	0.0213	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00472	0.0202	CbGpPWpGaD
Vardenafil—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0136	CcSEcCtD
Vardenafil—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0136	CcSEcCtD
Vardenafil—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.0134	CcSEcCtD
Vardenafil—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00457	0.0133	CcSEcCtD
Vardenafil—PDE1B—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.00456	0.0196	CbGpPWpGaD
Vardenafil—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.0132	CcSEcCtD
Vardenafil—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.013	CcSEcCtD
Vardenafil—PDE5A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.00442	0.019	CbGpPWpGaD
Vardenafil—PDE10A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.00442	0.019	CbGpPWpGaD
Vardenafil—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.0129	CcSEcCtD
Vardenafil—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.0128	CcSEcCtD
Vardenafil—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00438	0.0128	CcSEcCtD
Vardenafil—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.0123	CcSEcCtD
Vardenafil—PDE5A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.0042	0.018	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.0042	0.018	CbGpPWpGaD
Vardenafil—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.0042	0.0122	CcSEcCtD
Vardenafil—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00419	0.0122	CcSEcCtD
Vardenafil—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.0122	CcSEcCtD
Vardenafil—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00416	0.0121	CcSEcCtD
Vardenafil—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.0121	CcSEcCtD
Vardenafil—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.012	CcSEcCtD
Vardenafil—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.012	CcSEcCtD
Vardenafil—PDE1B—Signaling by PDGF—COL4A4—focal segmental glomerulosclerosis	0.00406	0.0174	CbGpPWpGaD
Vardenafil—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.0118	CcSEcCtD
Vardenafil—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.0039	0.0114	CcSEcCtD
Vardenafil—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00389	0.0113	CcSEcCtD
Vardenafil—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.0111	CcSEcCtD
Vardenafil—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.011	CcSEcCtD
Vardenafil—PDE1B—Signaling by PDGF—COL4A1—focal segmental glomerulosclerosis	0.00373	0.016	CbGpPWpGaD
Vardenafil—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.0107	CcSEcCtD
Vardenafil—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.0102	CcSEcCtD
Vardenafil—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.01	CcSEcCtD
Vardenafil—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00987	CcSEcCtD
Vardenafil—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00972	CcSEcCtD
Vardenafil—PDE1B—G Protein Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00331	0.0142	CbGpPWpGaD
Vardenafil—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.00959	CcSEcCtD
Vardenafil—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00328	0.00955	CcSEcCtD
Vardenafil—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.00921	CcSEcCtD
Vardenafil—PDE11A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00316	0.0135	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—COL4A3—focal segmental glomerulosclerosis	0.00315	0.0135	CbGpPWpGaD
Vardenafil—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00905	CcSEcCtD
Vardenafil—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00905	CcSEcCtD
Vardenafil—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00905	CcSEcCtD
Vardenafil—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00902	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00899	CcSEcCtD
Vardenafil—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00894	CcSEcCtD
Vardenafil—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00885	CcSEcCtD
Vardenafil—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.00868	CcSEcCtD
Vardenafil—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00862	CcSEcCtD
Vardenafil—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00851	CcSEcCtD
Vardenafil—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00843	CcSEcCtD
Vardenafil—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00839	CcSEcCtD
Vardenafil—PDE5A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00281	0.0121	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00281	0.0121	CbGpPWpGaD
Vardenafil—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00791	CcSEcCtD
Vardenafil—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00785	CcSEcCtD
Vardenafil—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.00779	CcSEcCtD
Vardenafil—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00774	CcSEcCtD
Vardenafil—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00771	CcSEcCtD
Vardenafil—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00764	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00749	CcSEcCtD
Vardenafil—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00742	CcSEcCtD
Vardenafil—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00715	CcSEcCtD
Vardenafil—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.0071	CcSEcCtD
Vardenafil—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00686	CcSEcCtD
Vardenafil—PDE11A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00226	0.00971	CbGpPWpGaD
Vardenafil—PDE1B—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.00224	0.00962	CbGpPWpGaD
Vardenafil—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00639	CcSEcCtD
Vardenafil—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00623	CcSEcCtD
Vardenafil—PDE1B—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00213	0.00914	CbGpPWpGaD
Vardenafil—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00614	CcSEcCtD
Vardenafil—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00594	CcSEcCtD
Vardenafil—PDE10A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00202	0.00865	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00202	0.00865	CbGpPWpGaD
Vardenafil—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00574	CcSEcCtD
Vardenafil—PDE11A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00189	0.00812	CbGpPWpGaD
Vardenafil—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00552	CcSEcCtD
Vardenafil—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00547	CcSEcCtD
Vardenafil—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00547	CcSEcCtD
Vardenafil—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00544	CcSEcCtD
Vardenafil—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00515	CcSEcCtD
Vardenafil—PDE10A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00169	0.00723	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00169	0.00723	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00143	0.00614	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00143	0.00612	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00142	0.0061	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.00138	0.00592	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00134	0.00577	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.0013	0.00557	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00129	0.00554	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00127	0.00547	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00127	0.00544	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00123	0.0053	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00123	0.00527	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0012	0.00514	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0012	0.00513	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.00119	0.00512	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00116	0.00497	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00115	0.00494	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00113	0.00485	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00113	0.00483	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00111	0.00477	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0011	0.00472	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00109	0.00469	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00109	0.00466	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00107	0.00457	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00104	0.00448	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00102	0.00439	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.001	0.0043	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.001	0.0043	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000993	0.00426	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000991	0.00425	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000991	0.00425	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000975	0.00418	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000968	0.00415	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000954	0.00409	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000939	0.00403	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000936	0.00402	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000934	0.00401	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00093	0.00399	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000927	0.00398	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000885	0.0038	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000855	0.00367	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000842	0.00361	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000834	0.00358	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000834	0.00358	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000833	0.00357	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000833	0.00357	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000826	0.00355	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000769	0.0033	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000767	0.00329	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000763	0.00327	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00075	0.00322	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000702	0.00301	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000699	0.003	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000698	0.00299	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MYH9—focal segmental glomerulosclerosis	0.000695	0.00298	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000686	0.00294	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000684	0.00293	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00068	0.00292	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000646	0.00277	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000642	0.00276	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000641	0.00275	CbGpPWpGaD
Vardenafil—PDE6G—Disease—LPL—focal segmental glomerulosclerosis	0.00063	0.0027	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000623	0.00267	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000607	0.0026	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000591	0.00254	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000587	0.00252	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000587	0.00252	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000587	0.00252	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000583	0.0025	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000572	0.00245	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000558	0.00239	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00054	0.00232	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000537	0.0023	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000527	0.00226	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000527	0.00226	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000523	0.00224	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000508	0.00218	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000502	0.00215	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000497	0.00213	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000494	0.00212	CbGpPWpGaD
Vardenafil—PDE6G—Disease—NOS2—focal segmental glomerulosclerosis	0.000492	0.00211	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00049	0.0021	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000483	0.00207	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000471	0.00202	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000457	0.00196	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000455	0.00195	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000449	0.00192	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000443	0.0019	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000441	0.00189	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00043	0.00185	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000423	0.00181	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000422	0.00181	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD79A—focal segmental glomerulosclerosis	0.000421	0.00181	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000419	0.0018	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000418	0.00179	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000415	0.00178	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000413	0.00177	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000407	0.00175	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000381	0.00164	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00038	0.00163	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000378	0.00162	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000368	0.00158	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000349	0.0015	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000348	0.00149	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000347	0.00149	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000345	0.00148	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000343	0.00147	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00034	0.00146	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000317	0.00136	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000316	0.00135	CbGpPWpGaD
Vardenafil—PDE1B—Disease—LPL—focal segmental glomerulosclerosis	0.000311	0.00134	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00029	0.00125	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00029	0.00124	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000283	0.00121	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000267	0.00115	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000265	0.00114	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—focal segmental glomerulosclerosis	0.000262	0.00112	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS2—focal segmental glomerulosclerosis	0.000243	0.00104	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000243	0.00104	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000225	0.000964	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000222	0.000954	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000218	0.000935	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000217	0.00093	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000206	0.000886	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000205	0.000878	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.0002	0.00086	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000186	0.0008	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000183	0.000786	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000179	0.000766	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000172	0.000739	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00017	0.00073	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00015	0.000643	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000143	0.000615	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000138	0.000592	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—focal segmental glomerulosclerosis	0.000129	0.000555	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00011	0.000471	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	0.000104	0.000445	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.05e-05	0.000388	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	8.88e-05	0.000381	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	7.91e-05	0.000339	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	6.96e-05	0.000299	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	6.81e-05	0.000292	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.41e-05	0.000275	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	4.83e-05	0.000207	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	4.13e-05	0.000177	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	3.17e-05	0.000136	CbGpPWpGaD
